These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25761573)

  • 1. Lrrk2 R1628P variant is a risk factor for essential tremor.
    Chao YX; Ng EY; Tan L; Prakash KM; Au WL; Zhao Y; Tan EK
    Sci Rep; 2015 Mar; 5():9029. PubMed ID: 25761573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential tremor and the common LRRK2 G2385R variant.
    Tan EK; Lee J; Lim HQ; Yuen Y; Zhao Y
    Parkinsonism Relat Disord; 2008 Nov; 14(7):569-71. PubMed ID: 18316234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2 variant associated with Alzheimer's disease.
    Zhao Y; Ho P; Yih Y; Chen C; Lee WL; Tan EK
    Neurobiol Aging; 2011 Nov; 32(11):1990-3. PubMed ID: 20018409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.
    Kim JM; Lee JY; Kim HJ; Kim JS; Shin ES; Cho JH; Park SS; Jeon BS
    Parkinsonism Relat Disord; 2010 Feb; 16(2):85-8. PubMed ID: 19854095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China.
    Yu L; Hu F; Zou X; Jiang Y; Liu Y; He X; Xi J; Liu L; Liu Z; He L; Xu Y
    Brain Res; 2009 Nov; 1296():113-6. PubMed ID: 19699188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LRRK2 I2012T, G2019S and I2020T mutations are not common in patients with essential tremor.
    Deng H; Le W; Davidson AL; Xie W; Jankovic J
    Neurosci Lett; 2006 Oct; 407(2):97-100. PubMed ID: 16939701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation of the association between LRRK2 R1628P variant and susceptibility to Parkinson's disease in the Thai population.
    Pulkes T; Papsing C; Thakkinstian A; Pongpakdee S; Kulkantrakorn K; Hanchaiphiboolkul S; Tiamkao S; Boonkongchuen P
    Parkinsonism Relat Disord; 2014 Sep; 20(9):1018-21. PubMed ID: 24997548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between the LRRK2 R1628P variant and the risk of Parkinson's disease in Asian: a meta-analysis.
    Wang X; Zhang X; Xue L; Xie A
    Neurosci Lett; 2016 Jun; 623():22-7. PubMed ID: 27133195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
    Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
    Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.
    Zhang Z; Burgunder JM; An X; Wu Y; Chen W; Zhang J; Wang Y; Xu Y; Gou Y; Yuan G; Mao X; Peng R
    Mov Disord; 2009 Oct; 24(13):1902-5. PubMed ID: 19672984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
    Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
    Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRRK2 R1628P increases risk of Parkinson's disease: replication evidence.
    Tan EK; Tan LC; Lim HQ; Li R; Tang M; Yih Y; Pavanni R; Prakash KM; Fook-Chong S; Zhao Y
    Hum Genet; 2008 Oct; 124(3):287-8. PubMed ID: 18781329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
    Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
    Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-control analysis of LRRK2 protective variants in Essential Tremor.
    Ng ASL; Ng EYL; Tan YJ; Prakash KM; Au WL; Tan LCS; Tan EK
    Sci Rep; 2018 Mar; 8(1):5346. PubMed ID: 29593234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson-Related LRRK2 Mutation R1628P Enables Cdk5 Phosphorylation of LRRK2 and Upregulates Its Kinase Activity.
    Shu Y; Ming J; Zhang P; Wang Q; Jiao F; Tian B
    PLoS One; 2016; 11(3):e0149739. PubMed ID: 26930193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.
    Gaig C; Ezquerra M; Marti MJ; Muñoz E; Valldeoriola F; Tolosa E
    Arch Neurol; 2006 Mar; 63(3):377-82. PubMed ID: 16533964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between the LRRK2 A419V variant and Asian Parkinson's disease.
    Gopalai AA; Lim SY; Aziz ZA; Lim SK; Tan LP; Chong YB; Tan CT; Puvanarajah S; Viswanathan S; Kuppusamy R; Tan AH; Lim TT; Eow GB; Norlinah MI; Li HH; Zhao Y; Ahmad-Annuar A
    Ann Acad Med Singap; 2013 May; 42(5):237-40. PubMed ID: 23771111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the Parkinson's disease genes, Leucine Rich Repeat Kinase 2 (LRRK2) and Glucocerebrosidase (GBA), are not associated with essential tremor.
    Clark LN; Kisselev S; Park N; Ross B; Verbitsky M; Rios E; Alcalay RN; Lee JH; Louis ED
    Parkinsonism Relat Disord; 2010 Feb; 16(2):132-5. PubMed ID: 19527940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of LRRK2 R1628P variant with Parkinson's disease in Ethnic Han-Chinese and subgroup population.
    Zhang P; Wang Q; Jiao F; Yan J; Chen L; He F; Zhang Q; Tian B
    Sci Rep; 2016 Nov; 6():35171. PubMed ID: 27812003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.